ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
First Trust Nasdaq Pharmaceuticals ETF
40.83
+0.1448
0.36%
盤後：
40.88
0.0452
+0.11%
19:30 EDT
成交量：
2.98萬
成交額：
121.56萬
市值：
10.51億
市盈率：
- -
高：
41.01
開：
40.70
低：
40.59
收：
40.69
52周最高：
42.87
52周最低：
27.30
股本：
2,575.00萬
流通股本：
2,575.00萬
量比：
1.44
換手率：
0.12%
股息：
0.42
股息率：
1.04%
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
強生股價盤前上漲1.2%，此前有報道稱阿波羅全球管理公司有意收購強生旗下骨科業務，潛在交易估值約為200億美元。
智通财经
·
09/14
強生Rybrevant聯合化療在EGFR外顯子20插入突變非小細胞肺癌中實現迄今報告最長的中位總生存期
美股速递
·
09/14
強生：RYBREVANT聯合化療在EGFR外顯子20插入突變非小細胞肺癌中實現已報告的最長中位總生存期。
智通财经
·
09/14
強生據報與阿波羅洽談約200億美元骨科業務交易
环球市场播报
·
09/13
傳阿波羅(APO.US)擬接盤強生(JNJ.US)骨科業務 潛在交易估值近200億美元
智通财经
·
09/12
據彭博社報導，阿波羅全球正就收購強生公司骨科業務部門進行談判
路透中文
·
09/12
據彭博社報道，阿波羅全球正就收購強生公司骨科業務部門進行談判
路透中文
·
09/12
據稱阿波羅正在洽談收購強生骨科業務部門。
智通财经
·
09/12
阿斯利康股價盤後跌超2%，因其三期臨床試驗結果令人失望。
智通财经
·
09/12
禮來完成對Ataibeckley收購，加速推進難治性抑鬱症及其他精神健康疾病療法研發
美股速递
·
09/11
無AI增長：八大精選股票
投资观察
·
09/11
媒體-禮來公司憑藉GLP-1帶來的意外之財，將用於推進女性健康業務——彭博社
路透中文
·
09/10
重發-艾伯維的經期偏頭痛治療藥物達到後期研究目標
路透中文
·
09/10
強生（JNJ）漲1.63% 新款雙周拋隱形眼鏡獲CE認證
金吾财讯
·
09/10
默沙東帕博利珠單抗三陰性乳腺癌適應症人群擴展在華獲批
智通财经
·
09/10
艾伯維高管：穩健資產負債表與長期成長空間並存，公司可兼顧早期及晚期業務拓展機會——電話會議實錄
美股速递
·
09/09
Leerink Partners上調默克目標價至161美元
格隆汇
·
09/09
百時美施貴寶(BMY)股票9月8日盤中下跌3.25%：真相來了
TradingKey中文
·
09/09
百時美施貴寶的療法達到了中期臨床試驗的目標
路透中文
·
09/08
施貴寶宣佈潛在首創GPRC5D靶向CAR T細胞療法Arlocabtagene Autoleucel註冊性II期關鍵試驗取得積極頂線結果
美股速递
·
09/08
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/FTXH/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FTXH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTXH\",,,,,undefined,":{"symbol":"FTXH","market":"US","secType":"STK","nameCN":"First Trust Nasdaq Pharmaceuticals ETF","latestPrice":40.8348,"timestamp":1789588800000,"preClose":40.69,"halted":0,"volume":29760,"hourTrading":{"tag":"盘后","latestPrice":40.88,"preClose":40.8348,"latestTime":"19:30 EDT","volume":20,"amount":817.524,"timestamp":1789601403872,"change":0.0452,"changeRate":0.001107,"amplitude":0},"delay":0,"changeRate":0.003558613910051698,"floatShares":25750002,"shares":25750002,"eps":0,"marketStatus":"已收盤","change":0.1448,"latestTime":"09-16 16:00:00 EDT","open":40.7,"high":41.01,"low":40.59,"amount":1215626.12352,"amplitude":0.010322,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789632000000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":40.69,"sharesOutstanding":850002,"nav":40.59,"aum":1045192581.18,"dividendRate":0.010371,"bidAskSpread":0.001837,"postHourTrading":{"tag":"盘后","latestPrice":40.88,"preClose":40.8348,"latestTime":"19:30 EDT","volume":20,"amount":817.524,"timestamp":1789601403872,"change":0.0452,"changeRate":0.001107,"amplitude":0},"volumeRatio":1.444829,"impliedVol":0.059,"impliedVolPercentile":0.5179},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTXH\",,,,,undefined,":{"symbol":"FTXH","floatShares":25750002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.444829,"shares":25750002,"dividePrice":0.4235,"high":41.01,"amplitude":0.010322,"preClose":40.69,"low":40.59,"week52Low":27.3,"pbRate":"--","week52High":42.87,"institutionHeld":0,"latestPrice":40.8348,"eps":0,"divideRate":0.010371,"volume":29760,"delay":0,"ttmEps":0,"open":40.7,"prevYearClose":32.9401,"prevWeekClose":40.4666,"prevMonthClose":41.3525,"prevQuarterClose":38.1897,"fiveDayClose":40.6998,"twentyDayClose":40.6534,"sixtyDayClose":35.8267},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FTXH\",params:#limit:5,,,undefined,":[{"date":"2026-06-25","symbol":"FTXH","amount":0.092,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2026-03-26","symbol":"FTXH","amount":0.0573,"announcedDate":"2026-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-26","defaultRemindTime":1774531800000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-26","currency":"USD","dateTimestamp":1774497600000,"payDate":"2026-03-31"},{"date":"2025-12-12","symbol":"FTXH","amount":0.1294,"announcedDate":"2025-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-12","defaultRemindTime":1765549800000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-12","currency":"USD","dateTimestamp":1765515600000,"payDate":"2025-12-31"},{"date":"2025-09-25","symbol":"FTXH","amount":0.1453,"announcedDate":"2025-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-25","defaultRemindTime":1758807000000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-25","currency":"USD","dateTimestamp":1758772800000,"payDate":"2025-09-30"},{"date":"2025-06-26","symbol":"FTXH","amount":0.0892,"announcedDate":"2025-06-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-26","defaultRemindTime":1750944600000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-30","payableDate":"2025-06-26","currency":"USD","dateTimestamp":1750910400000,"payDate":"2025-06-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FTXH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.0056,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.0286,"currency":"USD"},{"executeDate":"2017-03-23","recordDate":"2017-03-27","paymentDate":"2017-03-31","value":0.0313,"currency":"USD"},{"executeDate":"2017-06-22","recordDate":"2017-06-26","paymentDate":"2017-06-30","value":0.0553,"currency":"USD"},{"executeDate":"2017-09-21","recordDate":"2017-09-22","paymentDate":"2017-09-29","value":0.3448,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FTXH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FTXH\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667659843","title":"強生股價盤前上漲1.2%，此前有報道稱阿波羅全球管理公司有意收購強生旗下骨科業務，潛在交易估值約為200億美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667659843","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667659843?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 16:18","pubTimestamp":1789373891,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","PJP","IE00B42XCP33.USD","FTXH","AAUM","TRUH","FHLC","IE00BDGV0183.EUR","BK4184","LU1221951046.USD","IE0009355771.USD","LU0070217475.USD","LU2023250330.USD","MEDX","JNJ","IE000BZT7R73.USD","LU0320765646.SGD","LU1244550221.USD","LU2896262040.SGD","GDOC","LU0889566641.SGD","RXL","LU0345769128.USD","XLV","LU2592432038.USD","LBO","BMED","IXJ","GPZ","IE00BKVL7J92.USD","LU1430594728.SGD","IE00BN8TJ469.HKD","IE000WAW04H5.SGD","LU1032466523.USD","BK4559","LU1066053197.SGD","LU0882574055.USD","LU0289739343.SGD","LU0792757196.USD","VHT","LU1267930813.SGD","IYH","LU1066051225.USD","LU2430703251.USD","IHE","PRVT","LU0426412945.USD","APO","JDOC","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120093998","title":"強生Rybrevant聯合化療在EGFR外顯子20插入突變非小細胞肺癌中實現迄今報告最長的中位總生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=1120093998","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120093998?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 09:47","pubTimestamp":1789350464,"startTime":"0","endTime":"0","summary":"强生公司日前公布了一项重磅临床数据——其旗下药物Rybrevant与化疗联用，在携带EGFR外显子20插入突变的非小细胞肺癌患者中，取得了目前公开报告中最长的中位总生存期。EGFR外显子20插入突变，历来被视为治疗难点，可选方案有限且疗效欠佳。观察人士指出，这不仅能巩固Rybrevant在精准医疗版图中的地位，更可能重塑晚期非小细胞肺癌的一线治疗格局。强生能否借此在竞争激烈的肺癌药物市场中进一步扩大优势，值得持续跟踪。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2129689431.USD","LU2456880835.USD","LU1244550494.USD","LU0345769631.USD","LU1121112475.USD","LU1629891620.HKD","IE00B7SZLL34.SGD","LU1778281490.HKD","IE00BSNM7G36.USD","LU0320765646.SGD","LU1066051498.USD","LU1066051811.HKD","LU2133065610.SGD","LU0289961442.SGD","SG9999002232.USD","IE000M9KFDE8.USD","LU2236285917.USD","IE00BZ1G4Q59.USD","LU1196500208.SGD","IE000SO60NU8.SGD","BK4588","IE0034235303.USD","LU0545562505.USD","BMED","IE000WAW04H5.SGD","LU1430594728.SGD","BK4504","LU0210536198.USD","LU2471134523.USD","BK4533","BK4581","TRUH","LU2403377893.USD","LU2417539215.USD","LU1066051225.USD","LU2129689605.HKD","IE00BJJMRZ35.SGD","LU0795875169.SGD","LU1989771016.USD","IE00B19Z3581.USD","LU1929549753.HKD","LU1145028129.USD","LU1228905540.USD","IXJ","LU1057294990.SGD","JNJ","LU0994945656.USD","LU2213496289.HKD","LU0795875086.SGD","SG9999001440.SGD","IE00B2B36J28.USD","LU2430703095.HKD","LU1551013425.SGD","LU2756315318.SGD","LU0792757196.USD","IE00B19Z3B42.SGD","IE00BFXG1179.USD","LU0345769128.USD","LU1074936037.SGD","LU2487616109.SGD","LU0070217475.USD","LU1718418525.SGD","LU0640476718.USD","LU1032955483.USD","BK4007","IE00BLSP4239.USD","LU0057025933.USD","IE0002270589.USD","LU1674673428.USD","LU1244550221.USD","IE00BGHQF631.EUR","LU2023250330.USD","IE00BVYPNV92.GBP","LU0203345920.USD","LU1267930813.SGD","LU0466842654.USD","LU1221951129.SGD","IE000F7OJYX1.SGD","LU2756315664.SGD","LU0345770993.USD","LU0114720955.EUR","IE00B3PB1722.GBP","LU0426412945.USD","IE000MB6IJN5.SGD","SGXZ80539844.SGD","LU0820561818.USD","LU1674673691.USD","LU1914381329.SGD","LU2430703251.USD","LU2592432038.USD","LU0345770308.USD","LU1894683348.USD","LU0472753341.HKD","RXL","LU0689472784.USD","LU0124676726.USD","BK4550","LU0882574055.USD","SG9999001176.SGD","IE00BKVL7J92.USD","LU0426417589.USD","LU1244550577.SGD","LU1732800096.USD","IE00BBT3K403.USD","LU1162221912.USD","LU0122379950.USD","LU0964807845.USD","LU1221951046.USD","LU1059921491.USD","VHT","LU1506573853.SGD","IE000BZT7R73.USD","LU1061106388.HKD","LU2602419157.SGD","BK4534","IE00BN8TJ469.HKD","BK4585","IE00BDGV0183.EUR","LU0820561909.HKD","LU0069063385.USD","IE00BFTCPJ56.SGD","BK4532","SG9999013999.USD","LU0203347892.USD","LU1228905037.USD","BK4559","LU0098860793.USD","LU0787776722.HKD","LU1585245621.USD","LU2089984988.USD","MEDX","LU1935042991.SGD","LU0432979614.USD","IE00B1BXHZ80.USD","IE0001KFT4U8.USD","LU1032466523.USD","IYH","LU0820562030.AUD","LU1983299246.USD","LU0289739699.SGD","LU1894683264.USD","SGXZ57979304.SGD","LU0689626769.HKD","LU0053666078.USD","IE00BJT1NW94.SGD","LU0683600562.USD","IE00B42XCP33.USD","LU0889566641.SGD","LU0162691827.USD","LU2347655156.SGD","IE00B3T34201.USD","LU1043141123.HKD","JDOC","IE00BVYPNW00.USD","LU1066053197.SGD","LU0943347566.SGD","IHE","LU0058720904.USD","LU2468319806.SGD","LU1551013342.USD","FTXH","GDOC","IE0000B7K699.USD","LU0912757837.SGD","LU2471134879.HKD","LU0234570918.USD","LU1280957306.USD","LU1732799900.SGD","LU1496350502.SGD","LU2471134952.CNY","LU2505996681.GBP","LU1043141396.HKD","BK4568","LU0234572021.USD","FHLC","IE00BLSP4452.SGD","LU0289739343.SGD","LU0210528500.USD","IE0002141913.USD","LU2471134796.USD","XLV","SG9999001176.USD","LU2129689514.USD","LU2112291526.USD","LU2896262040.SGD","LU2505996509.AUD","LU1023059063.AUD","LU1261432733.SGD","LU2430703178.SGD","IE00B4R5TH58.HKD","LU2750360641.GBP","LU0985320562.USD","LU1291159041.SGD","BK4592","SG9999002224.SGD","LU0511384066.AUD","LU0072461881.USD","PJP","LU2750360997.AUD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667631840","title":"強生：RYBREVANT聯合化療在EGFR外顯子20插入突變非小細胞肺癌中實現已報告的最長中位總生存期。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667631840","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667631840?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 09:46","pubTimestamp":1789350398,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IXJ","LU1145028129.USD","BK4550","IE00BLSP4239.USD","GDOC","LU0683600562.USD","LU0053666078.USD","BK4568","BMED","FHLC","LU0511384066.AUD","LU2471134523.USD","BK4559","FTXH","IE00BGHQF631.EUR","XLV","IE00BFTCPJ56.SGD","IYH","LU2471134879.HKD","MEDX","LU1244550494.USD","BK4533","IE00BDGV0183.EUR","LU0122379950.USD","TRUH","LU0985320562.USD","LU2133065610.SGD","JNJ","LU1032466523.USD","LU1674673691.USD","BK4588","LU0820561909.HKD","IHE","LU1894683264.USD","IE0002141913.USD","RXL","IE0000B7K699.USD","IE00BVYPNV92.GBP","PJP","IE0001KFT4U8.USD","IE00B3T34201.USD","LU2592432038.USD","LU1935042991.SGD","JDOC","LU2089984988.USD","LU2430703095.HKD","LU1280957306.USD","VHT","LU0426417589.USD","LU0072461881.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667329689","title":"強生據報與阿波羅洽談約200億美元骨科業務交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2667329689","media":"环球市场播报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667329689?lang=zh_tw&edition=fundamental","pubTime":"2026-09-13 14:27","pubTimestamp":1789280820,"startTime":"0","endTime":"0","summary":"据知情人士消息，阿波罗全球管理公司正洽谈收购强生旗下以DePuy Synthes为主体的骨科业务，交易金额约为200亿美元。知情人士称，强生与阿波罗正在就出售展开谈判，但双方仍可能无法达成交易，强生也可能选择其他买家。强生和阿波罗目前均未公布交易安排。以当前报道的约200亿美元交易金额计算，潜在售价与强生当年的实际收购价格大致相当，但期间业务范围、财务表现和资产构成已经发生变化。此次潜在出售也是强生持续调整业务组合的一部分。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-09-13/doc-inirskha4546532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["VHT","LU2456880835.USD","TRUH","LU1228905540.USD","LU2023250330.USD","IE000F7OJYX1.SGD","IYH","LU0122379950.USD","IE00B19Z3581.USD","LU1496350502.SGD","LU0889566641.SGD","LU0640476718.USD","PJP","IE0009355771.USD","LU0792757196.USD","LU0426412945.USD","BMED","LU1778281490.HKD","FTXH","IE00B42XCP33.USD","IE00B4R5TH58.HKD","JNJ","IE00BVYPNV92.GBP","LU2089984988.USD","LU0795875169.SGD","LU1066053197.SGD","LU1732800096.USD","LU2430703251.USD","LU1935042991.SGD","RXL","GDOC","IXJ","LU0689472784.USD","LU0795875086.SGD","LU0545562505.USD","XLV","IE00BFXG1179.USD","LU2896262040.SGD","IHE","LU1074936037.SGD","LU2471134523.USD","LU2129689431.USD","MEDX","LU1059921491.USD","LU1430594728.SGD","LU2213496289.HKD","JDOC","LU0057025933.USD","FHLC","LU0820561909.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666508051","title":"傳阿波羅(APO.US)擬接盤強生(JNJ.US)骨科業務 潛在交易估值近200億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666508051","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666508051?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 11:04","pubTimestamp":1789182275,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据媒体援引知情人士消息报道，全球另类资产管理公司阿波罗全球管理 正洽谈收购强生的骨科业务部门DePuy Synthes。这笔交易对该业务的估值可能接近200亿美元。强生的骨科业务部门DePuy Synthes主要生产关节植入物和手术器械，2025年创造了93亿美元的收入，但收入增速仅为1.1%。相比之下，强生2025年整体营收同比增长6%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495305.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["FHLC","GDOC","MEDX","IYH","IXJ","JNJ","LU1267930813.SGD","LU2112291526.USD","IE00BGHQF631.EUR","LU1162221912.USD","LU2602419157.SGD","LU1506573853.SGD","IHE","APO","BMED","LU0345769631.USD","VHT","LU0689626769.HKD","LU2471134796.USD","LU0545562505.USD","LU1066051498.USD","IE00B3T34201.USD","RXL","XLV","IE00B42XCP33.USD","IE0001KFT4U8.USD","LU0912757837.SGD","LU1989771016.USD","LBO","LU1244550494.USD","LU2468319806.SGD","LU2487616109.SGD","TRUH","LU2471134523.USD","PRVT","IE000F7OJYX1.SGD","LU0006061336.USD","LU1057294990.SGD","LU1032466523.USD","BK4585","FTXH","JDOC","LU2129689431.USD","PJP","LU2756315318.SGD","GPZ","LU1668664300.SGD","IE000BZT7R73.USD","IE00B775SV38.USD","AAUM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666778075","title":"據彭博社報導，阿波羅全球正就收購強生公司骨科業務部門進行談判","url":"https://stock-news.laohu8.com/highlight/detail?id=2666778075","media":"路透中文","labels":["corporation","merge","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666778075?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 06:42","pubTimestamp":1789166537,"startTime":"0","endTime":"0","summary":"据彭博社报导，阿波罗全球正就收购强生公司骨科业务部门进行谈判路透9月11日-据彭博社周五援引消息人士报导，阿波罗全球管理公司（Apollo Global Management，APO.N）正在就收购强生公司（Johnson & JohnsonJNJ.N）旗下骨科业务部门进行磋商，该交易可能使该业务部门的估值接近200亿美元。路透无法立即核实该报导。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nL4T4531JU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BVYPNW00.USD","LU1228905540.USD","LU0345770993.USD","IE00BGHQF631.EUR","VHT","LU0114720955.EUR","LU0795875086.SGD","IYH","BK4592","LU1551013342.USD","AAUM","LU2347655156.SGD","IXJ","LU1323610961.USD","BMED","FTXH","LU1929549753.HKD","JDOC","TRUH","LU1668664300.SGD","RXL","IHE","GDOC","LU0234572021.USD","BK4588","LU1430594728.SGD","FHLC","LU1066051498.USD","LU1221951046.USD","LU2129689514.USD","LU0122379950.USD","LU2487616109.SGD","LU0985320562.USD","IE00BSNM7G36.USD","PRVT","LU2750360641.GBP","APO","PJP","XLV","JNJ","GPZ","LU2471134523.USD","MEDX","LU1032955483.USD","LU1778281490.HKD","BK4007","LU1585245621.USD","LU0203347892.USD","LBO","LU2112291526.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666577802","title":"據彭博社報道，阿波羅全球正就收購強生公司骨科業務部門進行談判","url":"https://stock-news.laohu8.com/highlight/detail?id=2666577802","media":"路透中文","labels":["corporation","merge","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666577802?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 06:42","pubTimestamp":1789166537,"startTime":"0","endTime":"0","summary":"据彭博社报道，阿波罗全球正就收购强生公司骨科业务部门进行谈判路透9月11日-据彭博社周五援引消息人士报道，阿波罗全球管理公司（Apollo Global Management，APO.N）正在就收购强生公司（Johnson & JohnsonJNJ.N）旗下骨科业务部门进行磋商，该交易可能使该业务部门的估值接近200亿美元。路透无法立即核实该报道。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nL4S4531JU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHLC","LU0820562030.AUD","LU0964807845.USD","LU1043141396.HKD","GDOC","MEDX","IYH","IXJ","JNJ","SG9999001176.USD","LU0234570918.USD","IE00BGHQF631.EUR","LU1935042991.SGD","LU2112291526.USD","LU1629891620.HKD","LU1506573853.SGD","LU1261432733.SGD","LU1894683264.USD","LU0882574055.USD","LU2756315664.SGD","IHE","LU1228905540.USD","APO","BK4504","BMED","IE000MB6IJN5.SGD","VHT","LU1221951129.SGD","LU2505996509.AUD","LU0203345920.USD","RXL","XLV","IE000M9KFDE8.USD","LU1989771016.USD","LBO","LU1196500208.SGD","TRUH","PRVT","BK4007","IE000F7OJYX1.SGD","IE00BFXG1179.USD","BK4585","JDOC","PJP","GPZ","IE00BKVL7J92.USD","LU0792757196.USD","FTXH","LU1059921491.USD","AAUM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666657206","title":"據稱阿波羅正在洽談收購強生骨科業務部門。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666657206","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666657206?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 06:25","pubTimestamp":1789165559,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SGXZ80539844.SGD","TRUH","LU2750360997.AUD","IE00BFXG1179.USD","IYH","LU0345770308.USD","IE0000B7K699.USD","LU0210536198.USD","LU0795875086.SGD","LU0943347566.SGD","FHLC","LU0964807845.USD","LU1221951046.USD","VHT","JDOC","SGXZ57979304.SGD","IE00B1BXHZ80.USD","IHE","LU0640476718.USD","LU2468319806.SGD","LU1057294990.SGD","LU0289739699.SGD","IE000SO60NU8.SGD","LU2756315664.SGD","XLV","IXJ","LU2487616109.SGD","LU1066051498.USD","LU0345770993.USD","LU2133065610.SGD","LU1244550221.USD","IE000WAW04H5.SGD","LU1732800096.USD","BMED","LU0689472784.USD","LU2213496289.HKD","LU0820562030.AUD","LU0985320562.USD","RXL","JNJ","GDOC","PJP","SG9999001440.SGD","MEDX","SG9999001176.USD","FTXH","IE00BGHQF631.EUR","IE00BZ1G4Q59.USD","LU0787776722.HKD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666571008","title":"阿斯利康股價盤後跌超2%，因其三期臨床試驗結果令人失望。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666571008","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666571008?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 04:23","pubTimestamp":1789158183,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GNOM","SYNB","LU2322448791.USD","TMED","LFSC","HELX","LU1992135399.USD","PBE","BK4585","FTXH","BBH","CANC","LU2272731600.USD","LU2272731865.HKD","RSPH","PSCH","IBB","IDNA","IEIH","MRNY","XBIX","BK4588","FBT","BME","RXL","AZNH","LU2322448957.HKD","PJP","XPH","IEHS","LU2272731782.SGD","WDNA","IBRN","BIOY","LU2473716301.USD","IYH","MEDI","IE00B5TLWC47.USD","BBP","MRNX","LU1992135472.HKD","BIB","PPH","PBPH","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154710349","title":"禮來完成對Ataibeckley收購，加速推進難治性抑鬱症及其他精神健康疾病療法研發","url":"https://stock-news.laohu8.com/highlight/detail?id=1154710349","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154710349?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 21:04","pubTimestamp":1789131857,"startTime":"0","endTime":"0","summary":"礼来公司已正式完成对Ataibeckley的收购事宜。这一战略举措，旨在为那些饱受难治性抑郁症以及其他精神健康疾病困扰的患者，开辟全新的治疗路径。此项交易的落定，标志着礼来在精神健康领域的布局迈出了坚实一步。礼来此番动作，显然意在突破这一瓶颈。通过将Ataibeckley的研发资产与专业团队纳入麾下，礼来有望整合各方资源，加速相关候选药物的研发进程。礼来此举，无疑将为其在精神科药物市场的未来竞争增添重要砝码。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLYZ","LU2028103732.USD","LU0106261372.USD","LU0353189680.USD","LU2089283258.USD","LU0889565916.HKD","IE00BK4W5L77.USD","LU2471134952.CNY","LU2552382215.SGD","SG9999014914.USD","FHLC","SG9999015952.SGD","IE00BJJMRX11.SGD","LU0114720955.EUR","IE00BJLML261.HKD","LU0466842654.USD","BK4585","LU0820562030.AUD","IE00B1XK9C88.USD","LU2237443622.USD","LU2237443895.HKD","IE00BJJMRY28.SGD","LU1979441026.SGD","LU2491050154.USD","SGXZ81514606.USD","HRTS","LLYX","IE00BK4W5M84.HKD","LU1280957306.USD","LU0158827781.USD","LU2168563687.JPY","LU2468319806.SGD","LU1093756325.SGD","FTXH","SG9999015945.SGD","LU0708995401.HKD","LU2108987350.USD","IE0004445239.USD","LU0882574055.USD","CURE","LU0345770308.USD","LU0096364046.USD","LU0109391861.USD","LU2471134879.HKD","LU2750360641.GBP","LU0417517546.SGD","GDOC","LU2237443465.HKD","LU0882574139.USD","LU0198837287.USD","WDNA","IE00BJJMRZ35.SGD","LU0006306889.USD","LU0256863902.USD","LU0289739699.SGD","LU0345770993.USD","LU0820561909.HKD","LU2361044865.SGD","LU2213496289.HKD","BK4581","LU1127390331.HKD","MEDI","LU0097036916.USD","LU0456855351.SGD","LU0174119429.USD","BK4588","LU0158827948.USD","LU0820561818.USD","LU0964807845.USD","PPH","LU0823416689.USD","LU1623119135.USD","BK4534","LU0225283273.USD","SGXZ57979304.SGD","LU1629891620.HKD","LU0432979614.USD","LU1720051108.HKD","LU2023251221.USD","LU1145028129.USD","IE00B2B36J28.USD","IE00B4JS1V06.HKD","LU2023250330.USD","LU0640476718.USD","LU1035775433.USD","LU2461242641.AUD","LU1232071149.USD","BK4533","JDOC","ELIS","ILDR","LU0256863811.USD","TMED","LU2211815571.USD","LU2361044949.HKD","LU1023059063.AUD","IE00B7KXQ091.USD","IE0002141913.USD","LU0109394709.USD","LU0061475181.USD","LU0210536198.USD","BK4516","LU2756315318.SGD","LU2417539215.USD","LU0266013472.USD","SG9999014880.SGD","LU2168564065.EUR","IXJ","MEDX","LU2896262040.SGD","LU1551013425.SGD","LU2271345857.HKD","IE00BN29S564.USD","LU2089284900.SGD","MHIP","LU1323610961.USD","LU2106854487.HKD","LU1551013342.USD","LU1974910355.USD","LU1691799644.USD","LU2264538146.SGD","LU2491050071.SGD","IE0001KFT4U8.USD","IE00BFTCPJ56.SGD","LU1868836591.USD","LU2168564149.EUR","LU2324357040.USD","LU0354030438.USD","LU2265009873.SGD","SG9999013999.USD","LU0316494557.USD","LLY","LU2602419157.SGD","LU0122379950.USD","LU0133085943.USD","LU0203201768.USD","LU0471298777.SGD","LU1988902786.USD","LU2089984988.USD","IE00BKDWB100.SGD","SG9999001176.USD","SG9999018865.SGD","SG9999014898.SGD","LU1868836914.USD","SG9999014906.USD","LU0471298694.HKD","LU2237443549.SGD","IYH","LU0823434583.USD","XLV","LU2462591350.SGD","LU2746668974.SGD","SGXZ99366536.SGD","LU1061106388.HKD","LU0787776722.HKD","LU2471134796.USD","IHE","SGXZ31699556.SGD","LU2471134523.USD","LU2112291526.USD","LU0786609619.USD","LU1057294990.SGD","LU0058720904.USD","LU2456880835.USD","IE0009355771.USD","LU0353189763.USD","LU1868837300.USD","LU2168564222.USD","LU2237438978.USD","LU2746668461.USD","LU0094547139.USD","LU2237443978.SGD","LU2063271972.USD","LU1069344957.HKD","LU0234572021.USD","LU0203202063.USD","LU1064131342.USD","ELIL","PJP","LU2168564495.EUR","LU1814569148.SGD","IE00BWXC8680.SGD","LU1804176565.USD","LU2491049909.HKD","RXL","LU0672654240.SGD","LU2552382132.HKD","SG9999015986.USD","LU0943347566.SGD","IE0005OL40V9.USD","LU1989771016.USD","LLII","LU0689472784.USD","LU2750360997.AUD","SG9999015978.USD","SG9999018857.SGD","IE00B775H168.HKD","SGXZ51526630.SGD","BK4007","IE00BFSS7M15.SGD","IE0004445015.USD","LU2361045086.USD","SG9999001176.SGD","LU1548497426.USD","LU1093756168.USD","LU0238689110.USD","GB00BDT5M118.USD","LU1917777945.USD","LU2360106947.USD","IE00B1BXHZ80.USD","LU1868836757.USD","LU1267930730.SGD","LU2756315664.SGD","LU0323591593.USD","AGNG","IE00BJT1NW94.SGD","LU0823434740.USD","SG9999017495.SGD","LU2357305700.SGD","IE00BKPKM429.USD","LU1720051017.SGD","VHT","LU2087625088.SGD","LU0320765992.SGD","IE00BFSS8Q28.SGD","LU2237443382.USD","TRUH","CANC","LU2236285917.USD","OZEM","LU1366192091.USD","LU1868837136.USD","BK4599","LU1712237335.SGD","LU2552382058.USD","LU2023250504.SGD","LU2111349929.HKD","LU0683600562.USD","LU0079474960.USD","LU0320765059.SGD","IE00B4R5TH58.HKD","LU0385154629.USD","LU1291159041.SGD","LU1983299246.USD","THNR","LU0354030511.USD","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114311100","title":"無AI增長：八大精選股票","url":"https://stock-news.laohu8.com/highlight/detail?id=1114311100","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114311100?lang=zh_tw&edition=fundamental","pubTime":"2026-09-11 13:06","pubTimestamp":1789103219,"startTime":"0","endTime":"0","summary":"人工智能究竟是一场第四次工业革命，还是一个超级泡沫？答案取决于你听的是华尔街哪位预言家的高论。它或将开启一个超级生产力周期，或将引发崩盘——亦或是两者兼而有之。它将攻克疾病与贫困，除非它先降低了大规模毁灭的门槛。有时实在令人疲惫不堪。以下八只颇具前景的股票，幸运地与AI关联甚微。没有事件视界，我们有的是一场盛大的电子游戏发布。我们不敢保证这份名单100%与AI绝缘。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRUH","LU2112291526.USD","LU2746668974.SGD","BK4517","LU2111349929.HKD","BK4142","BK4566","FTXH","SG9999014005.SGD","LU0234572021.USD","LU2265009873.SGD","LU1868836914.USD","SGXZ57979304.SGD","IE00B775H168.HKD","LU1983299246.USD","LU2602419157.SGD","LU1979441026.SGD","LU2552382058.USD","LU0471298694.HKD","IE00BJJMRY28.SGD","LU0158827948.USD","OZEM","SG9999014021.USD","LU2271345857.HKD","LU0174119429.USD","LU0320765992.SGD","IE00BKPKM429.USD","AGNG","LU2264538146.SGD","RCL","WDNA","IE00B4JS1V06.HKD","BK4127","THNR","LU2168564149.EUR","LU1057294990.SGD","LU0345774631.USD","SG9999014880.SGD","LU0256863811.USD","LU1670627923.USD","LU1551013425.SGD","LU0109391861.USD","LU1989771016.USD","LU0354030438.USD","LU2237443895.HKD","LU2417539215.USD","LU0310800379.SGD","LU2491050154.USD","LU0106831901.USD","LLYZ","LU1712237335.SGD","LU0980610538.SGD","LU2462157665.USD","LU0006306889.USD","LU1623119135.USD","LU0306806265.USD","SGXZ31699556.SGD","LU2106854487.HKD","LU1861217088.USD","LU0353189680.USD","LU0109394709.USD","LU1323610961.USD","LU2468319806.SGD","SG9999013999.USD","BK4200","LU2168564495.EUR","LU2552382132.HKD","LU0820561909.HKD","SG9999015978.USD","SWK","LU2023250504.SGD","LU1291159041.SGD","BK4534","LLY","LU1629891620.HKD","LU1974910355.USD","LU0061475181.USD","LU0385154629.USD","LU1145028129.USD","IHE","LU2361044949.HKD","IE00BK4W5L77.USD","LU2237443978.SGD","IE0002270589.USD","LU1280957306.USD","LU1868836591.USD","LU0964807845.USD","BK4504","LU1093756168.USD","CANC","LU1093756325.SGD","IE00BFTCPJ56.SGD","LU2087625088.SGD","LU0882574139.USD","LU0354030511.USD","LU1267930573.SGD","LU1074936037.SGD","LU0251142724.SGD","LU1720051017.SGD","LU2750360641.GBP","LU2213496289.HKD","VHT","LU2456880835.USD","LU2023250330.USD","LU0477156953.USD","SG9999001176.SGD","LU2462591350.SGD","LLII","WNDR","LU0097036916.USD","IE00B4R5TH58.HKD","LU0708994859.HKD","RXL","LU0882574055.USD","LU0787776722.HKD","LU1363072403.SGD","IE00BN29S564.USD","MEDX","LU0742534661.SGD","LU0820561818.USD","LU2471134879.HKD","LU2360107671.USD","LU2028103732.USD","LU2491049909.HKD","SG9999014914.USD","BK4516","BK4589","IE00BJJMRZ35.SGD","IE0002141913.USD","LU1861220207.SGD","LU0456855351.SGD","LU0466842654.USD","LU0345774391.USD","LU2896262040.SGD","LU2089283258.USD","FHLC","LU1670628061.USD","LU2168563687.JPY","LU0820562030.AUD","LU2361045086.USD","IE00B1BXHZ80.USD","LU0689472784.USD","LU0210536198.USD","LU0971096721.USD","LU0306807586.USD","SG9999015986.USD","ELIS","GB00BDT5M118.USD","SG9999014906.USD","LU0130102774.USD","LU0323591593.USD","LU1691799644.USD","LLYX","LU1791807156.HKD","SG9999001077.SGD","LU0471298777.SGD","LU0985481810.HKD","LU1668664300.SGD","LU0640476718.USD","IE00BWXC8680.SGD","BK4599","LU1035775433.USD","SG9999014039.USD","LU0133085943.USD","LU0128525929.USD","LU2357305700.SGD","LU2089984988.USD","LU2237443382.USD","SG9999001176.USD","LU1551013342.USD","GDOC","LU2237438978.USD","LU0417517546.SGD","XLV","LU2089284900.SGD","LU0029864427.USD","LU0316494557.USD","LU0011850046.USD","LU0251131958.USD","BK4581","LU2471134796.USD","LU1064131342.USD","LU0345770308.USD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","LU0225771236.USD","LU1201861249.SGD","LU0094547139.USD","LU1868837136.USD","FIVE","LU0079474960.USD","LU0114720955.EUR","SG9999015952.SGD","SG9999014898.SGD","LU0203201768.USD","LU2237443622.USD","BMRN","LU0320765059.SGD","IE00BFSS7M15.SGD","SGXZ99366536.SGD","LU0266013472.USD","IYH","IAI","IE00B7KXQ091.USD","LU2491050071.SGD","LU2471134952.CNY","LU0289739699.SGD","HRTS","LU2360106947.USD","LU2461242641.AUD","LU2168564065.EUR","IE00BJT1NW94.SGD","LU1127390331.HKD","LU0683600562.USD","LU2746668461.USD","IXJ","IE0004445239.USD","BK4585","LU1868837300.USD","LU2063271972.USD","LU0648001328.SGD","LU0198837287.USD","SG9999018865.SGD","IE00B7SZLL34.SGD","LU2023251221.USD","LU0048573561.USD","IE0005OL40V9.USD","MHIP","LU1035773651.USD","LU1917777945.USD","LU2750360997.AUD","PJP","LU0823416689.USD","LU1069347547.HKD","LU2237443549.SGD","IE000M9KFDE8.USD","LU0238689110.USD","LU2237443465.HKD","LU1267930730.SGD","ILDR","LU2108987350.USD","LU0943347566.SGD","LU1153585028.USD","IE0001KFT4U8.USD","LU0672654240.SGD","LU1720051108.HKD","LU1023059063.AUD","LU0130517989.USD","LU1548497426.USD","LU0122379950.USD","LU0432979614.USD","SCHW","LU2324357040.USD","LU1069344957.HKD","BK4533","LU0225283273.USD","LU1366192091.USD","LU2168564222.USD","IE00BJJMRX11.SGD","CURE","ELIL","TMED","SGXZ81514606.USD","LU0823434583.USD","LU1061106388.HKD","LU0256863902.USD","BK4588","BK4007","PPH","MEDI","JDOC","LU0158827781.USD","LU0353189763.USD","IE00BKDWB100.SGD","LU0321505439.SGD","SG9999015945.SGD","LU2236285917.USD","LU0096364046.USD","IE00B2B36J28.USD","LU2211815571.USD","LU0106261372.USD","SGXZ51526630.SGD","LU2552382215.SGD","SG9999017495.SGD","IE00BFSS8Q28.SGD","LU1232071149.USD","SG9999018857.SGD","IE00BK4W5M84.HKD","LU0889565916.HKD","IE0009355771.USD","LU1988902786.USD","BK4597","LU0708995401.HKD","LU1868836757.USD","LU2756315318.SGD","BK4161","BK4139","LU1804176565.USD","IE00BJLML261.HKD","LU0058720904.USD","LU0321505868.SGD","LU0203202063.USD","LU0823434740.USD","LU0786609619.USD","LU2361044865.SGD","LU2471134523.USD","LU2756315664.SGD","LU0225284248.USD","IE0004445015.USD","IE00B1XK9C88.USD","LU1814569148.SGD","LU0345770993.USD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666103599","title":"媒體-禮來公司憑藉GLP-1帶來的意外之財，將用於推進女性健康業務——彭博社","url":"https://stock-news.laohu8.com/highlight/detail?id=2666103599","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666103599?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 21:54","pubTimestamp":1789048489,"startTime":"0","endTime":"0","summary":"媒体-礼来公司凭借GLP-1带来的意外之财，将用于推进女性健康业务——彭博社9月10日--- 来源链接： (link)https://tinyurl.com/327fb793-- 注：路透尚未核实此报道，也不对其准确性负责","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nL4S452151:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1280957306.USD","SG9999014898.SGD","LU2471134523.USD","BK4581","IE0009355771.USD","LU1093756168.USD","SG9999015952.SGD","SG9999001176.SGD","LU1629891620.HKD","LU0689472784.USD","IE00BJLML261.HKD","GB00BDT5M118.USD","IE00B1BXHZ80.USD","LU0354030438.USD","LU0964807845.USD","VHT","LU2237443549.SGD","LU1145028129.USD","LU0174119429.USD","LU0417517546.SGD","FHLC","LU0943347566.SGD","LU1291159041.SGD","LU2087625088.SGD","LU2471134796.USD","LU2236285917.USD","IE0004445015.USD","LU0006306889.USD","LU0133085943.USD","LU2361044865.SGD","LU1057294990.SGD","LU1127390331.HKD","MHIP","SGXZ31699556.SGD","LU1712237335.SGD","LU0058720904.USD","ILDR","SG9999015978.USD","LU0787776722.HKD","LU2237443895.HKD","LU0114720955.EUR","LU0256863811.USD","SG9999014906.USD","LU0096364046.USD","IE00BK4W5L77.USD","LU0471298777.SGD","LU1804176565.USD","LU1974910355.USD","LU0061475181.USD","SG9999014880.SGD","CANC","LU0289739699.SGD","LU2746668974.SGD","MEDX","LU0823434740.USD","LU0203201768.USD","LU0823416689.USD","LU1623119135.USD","PPH","SG9999015945.SGD","SGXZ57979304.SGD","LU1988902786.USD","THNR","IE0002141913.USD","JDOC","LU2264538146.SGD","LU0106261372.USD","LU2237443978.SGD","SG9999018865.SGD","LU2237438978.USD","LU1720051017.SGD","IE00BN29S564.USD","LU0820561818.USD","IE00BKDWB100.SGD","SG9999018857.SGD","LU0672654240.SGD","LU2271345857.HKD","LU0158827948.USD","LU0345770993.USD","LU2360106947.USD","LU2750360641.GBP","LU0640476718.USD","TMED","LU2237443622.USD","LU0109391861.USD","LU2089284900.SGD","XLV","IE00BJJMRX11.SGD","LU0097036916.USD","LU0320765059.SGD","LU1323610961.USD","LU2552382058.USD","LU2552382132.HKD","LU2756315664.SGD","LU2756315318.SGD","LU1868837136.USD","HRTS","LU2168564495.EUR","LU2357305700.SGD","LU0786609619.USD","LU2112291526.USD","LU0823434583.USD","LU2211815571.USD","SGXZ81514606.USD","LU2265009873.SGD","LU0238689110.USD","LU0354030511.USD","GDOC","LU0820562030.AUD","LU0203202063.USD","LU0882574055.USD","LU0889565916.HKD","LU2111349929.HKD","LU2491050071.SGD","CURE","LU1989771016.USD","SG9999017495.SGD","LU0820561909.HKD","LU0109394709.USD","LU1917777945.USD","LU2108987350.USD","LU2471134952.CNY","LU0471298694.HKD","IE00BFSS7M15.SGD","IE00BJT1NW94.SGD","LU2324357040.USD","IE00B1XK9C88.USD","LU2462157665.USD","LU1551013425.SGD","RXL","LU2552382215.SGD","BK4588","LU0353189763.USD","IXJ","IE00B4JS1V06.HKD","IE00B775H168.HKD","LU2168564149.EUR","LLII","LU0210536198.USD","LU2417539215.USD","LU2750360997.AUD","LU2471134879.HKD","PJP","MEDI","LU1720051108.HKD","LU1868836914.USD","LU0708995401.HKD","LU2168564065.EUR","LU0225283273.USD","LLY","LU2468319806.SGD","BK4007","LU1061106388.HKD","LLYZ","LU0320765992.SGD","LU1069344957.HKD","BK4599","OZEM","LU2491050154.USD","BK4533","LU1064131342.USD","ELIL","LU0079474960.USD","BK4534","LU0256863902.USD","LU2461242641.AUD","LU1868836591.USD","IE00BWXC8680.SGD","IE0001KFT4U8.USD","LU2462591350.SGD","LU2491049909.HKD","LU1035775433.USD","BK4585","IE0004445239.USD","LU0266013472.USD","LU2089984988.USD","LU0122379950.USD","LU2361045086.USD","LU1548497426.USD","LU2237443465.HKD","TRUH","LU1551013342.USD","IE00BFTCPJ56.SGD","LU0345770308.USD","LU0385154629.USD","LU1868836757.USD","LU2361044949.HKD","LU2456880835.USD","LU2023251221.USD","SGXZ99366536.SGD","IE00B7KXQ091.USD","LLYX","LU1814569148.SGD","SGXZ51526630.SGD","LU1267930730.SGD","LU2237443382.USD","LU2168563687.JPY","LU0432979614.USD","LU2028103732.USD","SG9999014914.USD","LU2168564222.USD","LU0323591593.USD","LU2023250330.USD","LU2602419157.SGD","LU2023250504.SGD","AGNG","ELIS","IHE","LU0882574139.USD","LU2746668461.USD","LU2106854487.HKD","LU2896262040.SGD","LU0466842654.USD","SG9999001176.USD","LU0353189680.USD","IE00B4R5TH58.HKD","LU1868837300.USD","LU0316494557.USD","LU0234572021.USD","LU2213496289.HKD","IE00B2B36J28.USD","LU1366192091.USD","LU1983299246.USD","LU1023059063.AUD","LU1232071149.USD","IE00BJJMRY28.SGD","WDNA","LU0158827781.USD","IE00BFSS8Q28.SGD","LU0683600562.USD","FTXH","IE00BJJMRZ35.SGD","IE0005OL40V9.USD","LU0456855351.SGD","LU1979441026.SGD","IE00BK4W5M84.HKD","LU2089283258.USD","LU0198837287.USD","SG9999013999.USD","SG9999015986.USD","LU2063271972.USD","LU1093756325.SGD","LU1691799644.USD","LU0094547139.USD","IYH","IE00BKPKM429.USD","BK4516"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666599375","title":"重發-艾伯維的經期偏頭痛治療藥物達到後期研究目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2666599375","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666599375?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 21:38","pubTimestamp":1789047519,"startTime":"0","endTime":"0","summary":"艾伯维表示，服用阿托格潘特的患者平均比服用安慰剂的患者少0.8天的偏头痛天数。阿托格潘特属于针对偏头痛相关信号通路的治疗药物类别。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nL4S45213H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","LU0708994859.HKD","LU0256863811.USD","LU1291159041.SGD","GLAM","LU2089283258.USD","LU1934455194.USD","IYH","LU2129689431.USD","PPH","RXL","VHT","XLV","LU1093756168.USD","LU2237443549.SGD","TRUH","LU1236620834.HKD","AGNG","FTXH","LU0057025933.USD","IE000MB6IJN5.SGD","LU1236620750.USD","LU2129689514.USD","LU1934455863.HKD","LU0289961442.SGD","LU2125909247.SGD","LU1732799900.SGD","LU0069063385.USD","LU0820561909.HKD","LU0943347566.SGD","IE00BLSP4452.SGD","MEDX","LU0124676726.USD","LU2237443895.HKD","IE000BZT7R73.USD","SG9999015978.USD","LU0882574055.USD","LU0738911758.USD","LU0965509010.AUD","IE000WAW04H5.SGD","LU0211327993.USD","IXJ","ABBV","BK4559","LU1023059063.AUD","JDOC","LU0203345920.USD","BK4588","LU2089284900.SGD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666596063","title":"強生（JNJ）漲1.63% 新款雙周拋隱形眼鏡獲CE認證","url":"https://stock-news.laohu8.com/highlight/detail?id=2666596063","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666596063?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 21:21","pubTimestamp":1789046500,"startTime":"0","endTime":"0","summary":"金吾财讯 | 强生（JNJ）美股盘前股价震荡上行，最新涨1.63%，报271.4美元。消息面上，强生周四宣布，旗下新款ACUVUE OASYS MAX双周抛复用隐形眼镜已拿到CE认证。该款产品属于ACUVUE OASYS MAX产品线的新品，可在完整14天佩戴周期内保障佩戴舒适度与清晰视力。镜片搭载OptiBlue滤光技术、TearStable锁泪技术以及一类紫外线防护功能，专门面向长时间使用电子屏幕人群的用眼需求设计。上市节奏方面，计划2026年晚些时候率先登陆部分欧洲国家；后续视各地监管审批进度，在2027-2028年进一步拓展市场。目前该产品尚未取得美国FDA批准，暂未在美国市场销售。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250107/OGNjYWRkOTg0ZTNhODNlYjIwMzU4Nzc5OGE1MjIxNzAyOTY4ODU1OQ==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/OGNjYWRkOTg0ZTNhODNlYjIwMzU4Nzc5OGE1MjIxNzAyOTY4ODU1OQ==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305910","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","LU1228905037.USD","LU1244550494.USD","IE00BN8TJ469.HKD","IHE","FHLC","LU2750360997.AUD","TRUH","BK4532","LU0820562030.AUD","LU2756315318.SGD","LU2133065610.SGD","LU0124676726.USD","LU2456880835.USD","LU2505996509.AUD","RXL","LU0070217475.USD","BK4581","PJP","GDOC","LU1929549753.HKD","BMED","FTXH","BK4592","MEDX","LU1732800096.USD","LU0792757196.USD","LU1674673428.USD","LU0689626769.HKD","IE00BLSP4239.USD","IE00BGHQF631.EUR","LU0345770308.USD","LU0964807845.USD","IXJ","BK4559","LU1043141396.HKD","IE00BVYPNW00.USD","LU2750360641.GBP","IE000BZT7R73.USD","JNJ","LU1291159041.SGD","LU2756315664.SGD","VHT","LU1066053197.SGD","IE00BDGV0183.EUR","JDOC","IYH","LU0820561909.HKD","SG9999001440.SGD","LU0345770993.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666456659","title":"默沙東帕博利珠單抗三陰性乳腺癌適應症人群擴展在華獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2666456659","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666456659?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 16:21","pubTimestamp":1789028510,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1989772840.SGD","LU2491050071.SGD","LU0965509283.SGD","IE0009355771.USD","SG9999013999.USD","LU2361044865.SGD","LU0477156953.USD","LU0289739699.SGD","LU2023250504.SGD","LU0208291251.USD","LU0942090050.USD","IXJ","LU1162221912.USD","IE00BN8TJ469.HKD","TRUH","LU1066051498.USD","SG9999014575.USD","LU0234572021.USD","SG9999015358.SGD","LU1929549753.HKD","SG9999002224.SGD","LU0859254822.USD","LU1934455277.USD","PAWZ","LU0098860793.USD","LU0058720904.USD","LU0238689110.USD","LU1035773651.USD","LU0965508806.USD","LU1934455194.USD","LU1571399168.USD","LU1989772923.USD","LU2112291526.USD","LU2461242641.AUD","LU2361045086.USD","LU0265550946.USD","BK4516","LU0106261372.USD","SG9999001440.SGD","LU1201861249.SGD","LU0266013472.USD","LU1116320737.USD","LU1023059063.AUD","IE00BJT1NW94.SGD","LU2023250843.SGD","LU1923622614.USD","RXL","LU1917777945.USD","LU0861579265.USD","LU1585245621.USD","LU0211331839.USD","LU1061106388.HKD","BK4559","IE00BFTCPJ56.SGD","LU0432979614.USD","SG9999015341.SGD","SG9999014567.USD","IYH","LU1291159041.SGD","FTXH","LU1934455863.HKD","LU0868494617.USD","LU1941712348.USD","LU2125154778.USD","LU0130517989.USD","LU1066051225.USD","LU0122379950.USD","LU1037948897.HKD","IE00BLSP4452.SGD","LU1093756325.SGD","LU1032466523.USD","IHE","LU1989771016.USD","IE00BBT3K403.USD","LU0320765489.SGD","PPH","GDOC","SG9999014542.SGD","LU1057294990.SGD","JDOC","SG9999002232.USD","XLV","IE000M9KFDE8.USD","LU0070302665.USD","LU0868494708.USD","HRTS","LU2491049909.HKD","BK4533","BK4007","IE00BSNM7G36.USD","LU1983299246.USD","LU1116320901.HKD","IE0002141913.USD","LU2433249047.HKD","LU1066053197.SGD","LU1941712264.USD","LU0689626769.HKD","LU1066051811.HKD","LU0203347892.USD","LU0965509101.SGD","IE00B4R5TH58.HKD","BK4588","LU2360032135.SGD","LU1037948541.HKD","LU1093756168.USD","LU0965509010.AUD","LU0980610538.SGD","VHT","LU2089984988.USD","LU2361044949.HKD","BK4550","LU0124676726.USD","SG9999001176.USD","LU2125154935.USD","BMED","LU2357627491.SGD","LU0823416689.USD","LU0006306889.USD","LU1430594728.SGD","BK4534","IE00B1BXHZ80.USD","LU1699723380.USD","LU0648001328.SGD","LU0320765646.SGD","LU0130102774.USD","BK4585","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0265550359.USD","LU2106854487.HKD","LU1974910355.USD","LU2125909593.SGD","LU0985320562.USD","MRK","SG9999001176.SGD","LU0203345920.USD","LU1069347547.HKD","LU2324357040.USD","SGXZ57979304.SGD","LU2491050154.USD","LU2125909247.SGD","SG9999014559.SGD","LU2468319806.SGD","IE00BLSP4239.USD","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191303955","title":"艾伯維高管：穩健資產負債表與長期成長空間並存，公司可兼顧早期及晚期業務拓展機會——電話會議實錄","url":"https://stock-news.laohu8.com/highlight/detail?id=1191303955","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191303955?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 22:56","pubTimestamp":1788965760,"startTime":"0","endTime":"0","summary":"在近日一场备受关注的电话会议中，艾伯维公司高管明确表示，凭借其稳健的资产负债表以及充裕的长期增长跑道，公司目前能够同时审视并把握早期与晚期阶段的业务拓展契机。这一表态暗示，这家制药巨头在战略布局上拥有充分的灵活性与多元选择空间，既可着眼于处于萌芽阶段的创新资产，亦不排除对相对成熟项目的果断介入。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000BZT7R73.USD","LU1989772923.USD","LU2237443549.SGD","LU1929549753.HKD","BK4533","LU1057294990.SGD","LU1244550577.SGD","FHLC","IE00BLSP4452.SGD","LU0170899867.USD","LU1037948897.HKD","LU2133065610.SGD","XLV","IE000SO60NU8.SGD","BK4585","IE00B19Z3B42.SGD","IE00BBT3K403.USD","LU0545039389.USD","LU0661504455.SGD","PJP","LU0868494617.USD","LU2125909593.SGD","IE00BGHQF631.EUR","LU1934455863.HKD","LU1989771016.USD","LU0122379950.USD","SG9999003800.SGD","LU0211328371.USD","BK4581","LU0057025933.USD","LU1430594728.SGD","LU0158827948.USD","LU0708994859.HKD","LU0310800379.SGD","LU0124676726.USD","LU0820561909.HKD","LU0310799852.SGD","LU0912757837.SGD","LU2237443622.USD","LU0256863811.USD","LU2347655073.USD","IE00B3PB1722.GBP","IE0000B7K699.USD","LU1551013342.USD","LU0058720904.USD","IE0004445239.USD","LU1236620750.USD","LU2125909247.SGD","LU1670627923.USD","LU1267930573.SGD","IE00BJT1NW94.SGD","LU0289961442.SGD","LU0859254822.USD","LU2089984988.USD","MEDX","LU1037948541.HKD","IE00BVYPNV92.GBP","LU2129689431.USD","SG9999015986.USD","IE0009355771.USD","JDOC","LU0472753341.HKD","SG9999011175.SGD","LU2089284900.SGD","SG9999001440.SGD","LU1162221912.USD","IE00B4R5TH58.HKD","IE00BN8TJ469.HKD","LU2237443978.SGD","IE00B42XCP33.USD","LU0417517546.SGD","LU0114720955.EUR","LU0965508806.USD","IE00BVYPNW00.USD","LU1291159041.SGD","LU0689472784.USD","LU1244550221.USD","LU2112291526.USD","LU1934455277.USD","IE00BLSP4239.USD","LU1839511570.USD","LU0553294199.USD","IE0002141913.USD","LU0985320562.USD","LU0320765646.SGD","BK4559","LU0456855351.SGD","IE00BDGV0183.EUR","LU0234570918.USD","LU0868494708.USD","LU0965509010.AUD","LU0689626769.HKD","LU0098860793.USD","LU0738911758.USD","SG9999015945.SGD","LU0795875086.SGD","SG9999015978.USD","LU0726765562.USD","LU1670628061.USD","IE0002270589.USD","IE00B2B36J28.USD","LU1923622614.USD","LU2468319806.SGD","LU0029864427.USD","IE000MB6IJN5.SGD","LU2237443895.HKD","BK4534","LU2347655156.SGD","LU1496350171.SGD","LU0203345920.USD","IE00BJJMRZ35.SGD","SG9999015952.SGD","LU0211327993.USD","BK4139","LU0823416689.USD","LU1003077747.HKD","LU0882574055.USD","LU1267930490.SGD","IE000F7OJYX1.SGD","LU0861579265.USD","IE00BSNM7G36.USD","LU0795875169.SGD","LU1983299246.USD","LU2129689514.USD","LU0432979614.USD","LU1093756325.SGD","LU1023059063.AUD","GLAM","LU0128525929.USD","LU1732800096.USD","LU1093756168.USD","AGNG","LU0069063385.USD","BK4550","VHT","LU2237443465.HKD","LU0965509283.SGD","LU1496350502.SGD","IE000WAW04H5.SGD","LU0942090050.USD","LU0256863902.USD","LU1934455194.USD","IE00B19Z3581.USD","IXJ","LU0820561818.USD","LU1074936037.SGD","RXL","LU0395794307.EUR","LU0965509101.SGD","IYH","BK4588","IE00BFTCPJ56.SGD","LU2357627491.SGD","LU0203347892.USD","LU0511384066.AUD","LU2023251221.USD","LU1061106388.HKD","FTXH","LU0234572021.USD","LU2089283258.USD","LU0289739699.SGD","LU2129689605.HKD","ABBV","LU0289739343.SGD","TRUH","LU2087621335.USD","LU1244550494.USD","LU1585245621.USD","LU1718418525.SGD","LU0949170772.SGD","LU1236620834.HKD","LU1551013425.SGD","PPH","LU0198837287.USD","LU0943347566.SGD","BK4566","LU1732799900.SGD","LU1989772840.SGD","LU2237443382.USD","LU2433249047.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584416","title":"Leerink Partners上調默克目標價至161美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584416","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584416?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 18:22","pubTimestamp":1788949320,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["SGXZ57979304.SGD","IE00BLSP4239.USD","LU1923622614.USD","RXL","IYH","LU1201861249.SGD","LU1430594728.SGD","UUP","GDOC","LU0868494708.USD","BMED","IXJ","LU0648001328.SGD","LU0965509283.SGD","LU2491049909.HKD","LU0689626769.HKD","MRK","IE00BJT1NW94.SGD","LU1066051225.USD","SG9999014542.SGD","SG9999014567.USD","PPH","IHE","LU2468319806.SGD","LU0980610538.SGD","LU1035773651.USD","LU1941712264.USD","LU2357627491.SGD","LU0965509101.SGD","LU0098860793.USD","PAWZ","FTXH","VHT","LU2125909247.SGD","LU2125909593.SGD","LU0203345920.USD","UDN","LU2106854487.HKD","SG9999015358.SGD","LU0234572021.USD","JDOC","TRUH","FHLC","HRTS","LU0122379950.USD","LU0238689110.USD","XLV","BK4534","SG9999013999.USD","LU1934455863.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666137293","title":"百時美施貴寶(BMY)股票9月8日盤中下跌3.25%：真相來了","url":"https://stock-news.laohu8.com/highlight/detail?id=2666137293","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666137293?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 03:16","pubTimestamp":1788894989,"startTime":"0","endTime":"0","summary":"• 尽管 arlocabtagene autoleucel 的2期临床试验结果积极，百时美施贵宝仍面临获利回吐。\n• 由于监管时间表尚未明确以及近期临床试验暂停招募，投资者态度谨慎。\n• 该公司年收入为481.9亿美元，并维持着稳健的财务运营指标。","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262156751-market-movers-bmy-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1670710588.SGD","LU0225771236.USD","BK4007","LU1868836914.USD","LU1868836591.USD","LU0237698245.USD","BK4588","LU0114720955.EUR","LU0868494617.USD","LU0267386448.USD","LU0456855351.SGD","LU0432979614.USD","LU2596442595.SGD","IE0002141913.USD","LU0321505868.SGD","BK4559","IE0009355771.USD","LU0306806265.USD","LU1670710661.SGD","LU1989771016.USD","LU1868837300.USD","LU0882574055.USD","IE00BJT1NW94.SGD","LU2242646821.SGD","BK4532","FTXH","LU1291159041.SGD","LU1571399168.USD","LU2242652126.USD","LU0321505439.SGD","LU0225284248.USD","LU1323610961.USD","LU2125154778.USD","LU1430594728.SGD","IE00BFTCPJ56.SGD","BK4585","LU2125154935.USD","IE00B2B36J28.USD","LU0096364046.USD","LU0985481810.HKD","IE00BJJMRZ35.SGD","BMY","IHE","LU1236620834.HKD","LU1236620750.USD","LU1718418525.SGD","LU1868836757.USD","BK4534","LU0061475181.USD","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665912322","title":"百時美施貴寶的療法達到了中期臨床試驗的目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2665912322","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665912322?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 19:03","pubTimestamp":1788865396,"startTime":"0","endTime":"0","summary":"百时美施贵宝的疗法达到了中期临床试验的目标路透9月8日-百时美施贵宝公司（BMY.N）周二表示，其一种实验性细胞疗法达到了中期临床试验的主要目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4T4500S3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1236620750.USD","LU1868837136.USD","LU2360032135.SGD","LU1323610961.USD","LU1868836914.USD","LU1670711123.USD","LU1261432733.SGD","LU1291159041.SGD","LU0237698245.USD","BK4581","LU0882574055.USD","LU0225284248.USD","BMY","LU0985481810.HKD","IE00BSNM7G36.USD","BK4559","IE0009355771.USD","LU1670711040.USD","LU1868836591.USD","LU1430594728.SGD","LU1032466523.USD","LU1585245621.USD","BK4585","LU0061475181.USD","IE00BFXG1179.USD","LU2242646821.SGD","LU1074936037.SGD","IE00BJT1NW94.SGD","LU0868494617.USD","BK4534","LU0306807586.USD","BK4007","LU0432979614.USD","LU0267386448.USD","LU1236620834.HKD","BK4588","LU2133065610.SGD","LU0306806265.USD","LU2125154935.USD","IHE","LU1883839398.USD","LU0321505439.SGD","LU0321505868.SGD","LU1093756325.SGD","IE0002141913.USD","LU1989771016.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU1093756168.USD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145175985","title":"施貴寶宣佈潛在首創GPRC5D靶向CAR T細胞療法Arlocabtagene Autoleucel註冊性II期關鍵試驗取得積極頂線結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1145175985","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145175985?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 19:00","pubTimestamp":1788865214,"startTime":"0","endTime":"0","summary":"施贵宝今日披露，其研发的潜在首创GPRC5D靶向CAR T细胞疗法——Arlocabtagene Autoleucel，在注册性II期关键试验中收获积极顶线数据。施贵宝表示，完整的试验结果将在即将召开的科学会议上进行展示，同时公司计划与全球监管机构展开沟通，以推动该疗法的临床开发进程。这一里程碑式的进展，不仅彰显了施贵宝在细胞治疗领域的深厚布局，也再次印证了精准医疗在肿瘤学中的变革潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225284248.USD","BK4559","LU1670710588.SGD","BMY","LU0882574055.USD","LU1868836591.USD","IE00BFTCPJ56.SGD","LU0985481810.HKD","LU0225771236.USD","IE00BJT1NW94.SGD","LU2596442595.SGD","BK4007","LU2125154935.USD","LU1868837136.USD","LU1670711123.USD","LU1291159041.SGD","LU0321505439.SGD","IE00BJJMRZ35.SGD","LU2125154778.USD","FTXH","LU0868494617.USD","LU1074936037.SGD","LU1430594728.SGD","IE0002141913.USD","LU0237698245.USD","IE0009355771.USD","LU1868836914.USD","LU2242652126.USD","BK4534","IE00BSNM7G36.USD","LU0306806265.USD","LU0267386448.USD","BK4532","LU2133065610.SGD","BK4588","LU1670711040.USD","LU1261432733.SGD","IE00B2B36J28.USD","LU1868837300.USD","BK4581","IE00BFXG1179.USD","LU0456855351.SGD","LU0306807586.USD","LU1323610961.USD","LU1670710661.SGD","LU1868836757.USD","LU1093756168.USD","LU0096364046.USD","LU1032466523.USD","LU1236620750.USD","LU1571399168.USD","LU1718418525.SGD","BK4585","LU1883839398.USD","LU1989771016.USD","LU2242646821.SGD","LU0321505868.SGD","LU0114720955.EUR","LU1236620834.HKD","LU2360032135.SGD","LU1093756325.SGD","LU0432979614.USD","LU1983299246.USD","IHE","LU0061475181.USD","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}